Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomised trials

British Journal of Cancer

Volumn 91, Issue 4, 2004, Pages 683-687

  Bokemeyer, C ^a   Kollmannsberger, C ^a,b   Stenning, S ^c   Hartmann, J T ^a   Horwich, A ^d   Clemm, C ^e   Gerl, A ^f   Meisner, C ^a   Ruckerl C P ^a   Schmoll, H J ^g   Kanz, L ^a   Oliver, T ^h  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

^f Onkologische Praxis   (Germany)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Carboplatin; Cisplatin; Metastatic; Seminoma

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; HUMAN; LUNG CANCER; LUNG TOXICITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZATION; SEMINOMA; STANDARD; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 4344704483     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602020     Document Type: Article

References (15)

1. Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P (1993) Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 11: 598-606
2. Bokemeyer C, Kohrmann O, Tischler J, Weissbach L, Rath U, Haupt A, Schoffski P, Harstrick A, Schmoll HJ (1996) A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. Ann Oncol 7: 1015-1021
3. Bosl GJ, Motzer RJ (1997) Medical progress: testicular germ-cell cancer. N Engl J Med 337: 242-253
4. Clemm C, Bokemeyer C, Gerl A, Holzel D, Weissbach L, Bamberg M, Schoeffski P, Harstrick A, Schmoll HJ, Wilmanns W (2000) Randomized trial comparing cisplatin/etoposide/ifosfamide with carboplatin monochemotherapy in patients with advanced metastatic seminoma. Proc Am Soc Clin Oncol 19: 328 (abstract 1283)
5. Clemm C, Gerl A, Kohl P, Hentrich M, Hartenstein R, Gassel WD, Knutzen B, Wilmanns W (1993) Combination chemotherapy containing cisplatin/ifosfamide and vinblastine or etoposide in bulky seminoma. Eur J Cancer 29A(Suppl 6): S240 (abstract 1347)
6. Cox DR, Oakes D (1984) Analysis of survival data. London: Chapman and Hall
7. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777-1781
8. Fléchon A, Rivoire M, Biron P, Droz JP (2001) Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors. J Urol 165: 1920-1926
9. Horwich A, Dearnaley DP, A'Hern R, Mason M, Thomas G, Jay G, Nicholls J (1992) The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer 28A: 1307-1310
10. Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP (2000) A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Br J Cancer 83: 1623-1629
11. Horwich A, Sleijfer DT, Fossa SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP (1997) Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 15: 1844-1852
12. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. Am J Stat Assoc 53: 457-481
13. Mead G, for the International Germ Cell Cancer Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603
14. Oliver RT, Lore S, Ong J (1990) Alternatives to radiotherapy in the management of seminoma. Br J Urol 65: 61-67
15. Schmoll HJ, Harstrick A, Bokemeyer C, Dieckmann KP, Clemm C, Berdel WE, Souchon R, Schober C, Wilke H, Poliwoda H (1993) Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer 72: 237-243